Is Antimony trioxide (FR synergist) safe for babies and kids?
Moderate risk for kidsInfants are extremely vulnerable to Antimony trioxide (FR synergist) due to immature blood-brain barrier, higher gastrointestinal absorption rates (40-50% vs 3-10% in adults), and rapidly developing neurology. Even trace exposure can cause irreversible neurodevelopmental harm.
What is antimony trioxide (fr synergist)?
The IUPAC name is oxomagnesium.
Also known as: oxomagnesium, Magnesia, Granmag, Heavy magnesium oxide.
- IUPAC name
- oxomagnesium
- CAS number
- 1309-48-4
- Molecular formula
- MgO
- Molecular weight
- 40.305 g/mol
- SMILES
- O=[Mg]
- PubChem CID
- 14792
Risk for babies
Moderate riskInfants are extremely vulnerable to Antimony trioxide (FR synergist) due to immature blood-brain barrier, higher gastrointestinal absorption rates (40-50% vs 3-10% in adults), and rapidly developing neurology. Even trace exposure can cause irreversible neurodevelopmental harm.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
High riskPregnancy increases vulnerability to Antimony trioxide (FR synergist). Heavy metals cross the placenta, accumulate in fetal tissue, and interfere with neurodevelopment. Maternal bone resorption during pregnancy mobilizes stored metals.
Known reproductive toxicant (GHS H360) or confirmed endocrine disruptor. Placental transfer is presumed. Fetal exposure during critical developmental windows may cause structural malformations, growth restriction, or functional deficits.
Regulatory consensus
3 regulatory and scientific bodies have classified Antimony trioxide (FR synergist). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 6 positive / 0 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 6 positive / 0 negative reports) | |
| EPA CTX / Skin-Eye | — | Eye Irritation: Category 2 (score: high) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter antimony trioxide (fr synergist)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Antimony trioxide (FR synergist):
-
Inherently flame-resistant materials (wool, modacrylic, Nomex)
Trade-offs: Higher material cost. Limited color/texture options.Relative cost: 1.2-2×
-
Barrier fabric technology
Trade-offs: Adds manufacturing step and costRelative cost: 1.2-2×
Frequently asked questions
Is antimony trioxide (fr synergist) safe for kids?
Infants are extremely vulnerable to Antimony trioxide (FR synergist) due to immature blood-brain barrier, higher gastrointestinal absorption rates (40-50% vs 3-10% in adults), and rapidly developing neurology. Even trace exposure can cause irreversible neurodevelopmental harm.
What products contain antimony trioxide (fr synergist)?
Antimony trioxide (FR synergist) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to antimony trioxide (fr synergist)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
Why do regulators disagree about antimony trioxide (fr synergist)?
Antimony trioxide (FR synergist) has been classified by 3 agencies including EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Antimony trioxide (FR synergist) in the baby app
Look up products containing antimony trioxide (fr synergist), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- IARC Monographs Volume 47: Antimony Trioxide (Sb₂O₃) — Group 2B Possible Carcinogen, Inhalation-Route Lung Tumors in Rats, Limited Human Evidence from Smelter Workers, FR Synergist Applications (1989) (1989) — regulatory
- IARC Monographs Volume 100C: Antimony Trioxide — Group 2B Classification Maintained, Particle Lung Carcinogenicity, EU REACH Harmonized Classification Carc. 2 H351, NIOSH REL 0.5 mg Sb/m³ (2012) (2012) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →